Skip to main content
main-content

01.12.2016 | Research article | Ausgabe 1/2016 Open Access

BMC Psychiatry 1/2016

Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial

Zeitschrift:
BMC Psychiatry > Ausgabe 1/2016
Autoren:
Wai Tong Chien, Jolene Mui, Richard Gray, Eric Cheung
Wichtige Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Conception and study design: WTC, JM, EC and RG; Data collection, analysis and interpretation: WTC, RG and JM; Preparation for the manuscript: WTC; and, Final approval of the version to be published: JM, EC and RG. All authors read and approved the final manuscript.

Abstract

Background

Current practice guidelines for schizophrenia care recommend that antipsychotic medication is essential for patients’ long-term maintenance treatment but their non-adherence to this medication is still a main obstacle to relapse prevention. This study evaluated the effects of a motivational-interviewing-based adherence therapy for people with schizophrenia spectrum disorders.

Methods

This randomised controlled trial was conducted with 134 outpatients with schizophrenia spectrum disorders; 67 of them received a six-session adherence therapy (in addition to usual care) and 67 received usual psychiatric care alone. Participants’ outcome measures included symptom severity, medication adherence, hospitalisation rates, insight into illness/treatment, and functioning.

Results

The adherence therapy group reported significantly greater improvements in symptom severity (p < 0.003), insight into illness/treatment (p < 0.001), functioning (p < 0.005), duration of re-hospitalisations (p < 0.005), and medication adherence (p < 0.005) over 18 months follow-up, when compared with usual care alone.

Conclusions

Motivational-interviewing-based adherence therapy can be an effective approach to treatment for people with early stage of schizophrenia who poorly adhere to medication regimen.

Trial registration

ClinicalTrials.gov NCT01780116, registration date January 29, 2013.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2016

BMC Psychiatry 1/2016 Zur Ausgabe

Neu im Fachgebiet Psychiatrie